Print this page    •   Back to Web version of article

AIDS Drug Assistance Programs (ADAPs)

2001

Overview


New Clients and Continuing Clients, 1998-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Missing data are excluded from this graph. Race/Ethnicity data are unknown for 3,573 ADAP clients in 2001.
** Other includes American Indians, Alaska Natives, people of other races, and persons of two or more races. It should be noted that the category “other races” was expanded in 2000 to include two or more races.
*** Reports on the number of Hispanics served were found to have been inflated in previous report years making these data unreliable.


Distribution of Gender, 1998-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Missing data are excluded from this graph. Gender data are unknown for 63 ADAP clients in 2001.


Distribution of Race/Ethnicity, 1998-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Missing data are excluded from this graph. Race/Ethnicity data are unknown for 3,573 ADAP clients in 2001.
** Other includes American Indians, Alaska Natives, people of other races, and persons of two or more races. It should be noted that the category “other races” was expanded in 2000 to include two or more races.
*** Reports on the number of Hispanics served were found to have been inflated in previous report years making these data unreliable.


Distribution of Age, 1998-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Missing data are excluded from this graph. Age data are unknown for 79 ADAP clients in 2001.


Percent Reported Ryan White CARE Act Funding vs. Non-CARE Act Funding, 1998-2001
* Funding is as reported by grantees in the Annual Administrative Report and may not reflect actual Care Act funding.
** CARE Act funding includes Ryan White CARE Act Title I, Title II base, Title II ADAP earmark, and other Ryan White CARE Act funding. Other funding includes Medicaid, Medicare, Federal Section 329, 330, 340, other Federal, State and Local funding, other public payments, manufacturer rebates, private contributions, and client payments.
Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.


Percentage Distribution of Expenditures, 2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.
**Other expenditures includes ADAP funds used for administration and ancillary devices (e.g., tubing, nebulizers, etc.) needed to administer these therapies, adherence, access, and monitoring policy.


Percentage Distribution of Drugs and Other Expenditures, 1997-2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.
**Other expenditures includes ADAP funds used for administration and ancillary devices (e.g., tubing, nebulizers, etc.) needed to administer these therapies.


Total Drug Expenditures by Drug Classification, 2001
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001. Note: See appendix for list of drugs in each drug class.


Top Ten Medications Prescribed in 2001 by the Number of Clients
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.


Top Ten Medications Prescribed in 2001 by Expenditures
* Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.


Appendix: List of FDA-Approved Antiretroviral Medications by Drug Class, 2001


Appendix: List of FDA-Approved Opportunistic Infection (OI) Drugs, 2001
** No State ADAPs purchased this drug.
Ganciclovir is available as a PO, implant, or IV. Pentamidine is available aerosolized.




This article was provided by U.S. Health Resources and Services Administration. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art12385.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.